These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21963976)

  • 1. [Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile].
    Watanabe T; Satoh H; Hori S; Miki A; Ohtani H; Sawada Y
    Yakugaku Zasshi; 2011; 131(10):1483-92. PubMed ID: 21963976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
    Yoshihara S; Fukuda H; Abe T; Arisaka O
    Biol Pharm Bull; 2010; 33(10):1763-5. PubMed ID: 20930390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin permeability of tulobuterol in two transdermal formulations and their followability.
    Takizawa Y; Goto T; Sato S; Ohmori N; Mori K; Shimada Y; Chen K; Miyagi T; Fukai F
    Drug Discov Ther; 2017 Nov; 11(5):253-258. PubMed ID: 29021505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of systemic exposure of ketoprofen tapes by in vitro release test and pharmacokinetic model analysis: comparison between brand-name and generic formulations].
    Awa K; Satoh H; Hori S; Sawada Y
    Yakugaku Zasshi; 2012; 132(1):135-44. PubMed ID: 22214588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence of marketed transdermal delivery systems for tulobuterol.
    Tojo K; Hikima T
    Biol Pharm Bull; 2007 Aug; 30(8):1576-9. PubMed ID: 17666825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the predicted time-concentration profile of serum tulobuterol in human after transdermal application.
    Nakamura A; Mori D; Tojo K
    Chem Pharm Bull (Tokyo); 2012; 60(3):300-5. PubMed ID: 22382408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence assessment of tulobuterol transdermal delivery system in healthy subjects
.
    Park SI; Kim BH
    Int J Clin Pharmacol Ther; 2018 Aug; 56(8):381-386. PubMed ID: 29932416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
    Nan L; Song H; Wang H; Mi R; Wang X; Fang L
    Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
    Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
    Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic selection criteria for safety and patient benefit [Ⅻ]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape.
    Shimokawa KI; Yotsukura K; Nozawa M; Wada Y; Ishii F
    Drug Discov Ther; 2024 Jan; 17(6):409-414. PubMed ID: 38044119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration.
    Kim JH; Kim TH; Park HJ; Choi YJ; Kang JH; Song KH; Koo TS; Seo KW
    Vet J; 2016 Feb; 208():90-2. PubMed ID: 26639828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma].
    Kato H; Nagata O; Yamazaki M; Suzuki T; Nakano Y
    Yakugaku Zasshi; 2002 Jan; 122(1):57-69. PubMed ID: 11828751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation.
    Cawello W; Braun M; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):475-481. PubMed ID: 29332198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma.
    Iikura Y; Uchiyama H; Akimoto K; Ebisawa M; Sakaguchi N; Tsubaki T; Ishizu H; Kabayama H; Yagi K; Miura K
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):147-51. PubMed ID: 7697473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical attributes of transdermal drug delivery system (TDDS)--a generic product development review.
    Ruby PK; Pathak SM; Aggarwal D
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1421-8. PubMed ID: 24467407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
    Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
    Inoue H; Niimi A; Matsumoto H; Ito I; Oguma T; Otsuka K; Takeda T; Nakaji H; Tajiri T; Iwata T; Nagasaki T; Mishima M
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):21-29. PubMed ID: 27718262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.